Moderna to Present at Upcoming Conferences in June 2022

Rhea-AI Summary

Moderna (NASDAQ:MRNA) announced its upcoming participation in two major investor conferences: the 2022 Jefferies Healthcare Conference on June 8 at 3:00 p.m. ET and the 43rd Annual Goldman Sachs Global Healthcare Conference on June 14 at 12:20 p.m. ET. Live webcasts will be available on the Moderna investor website, with replays archived for at least 30 days. Moderna has evolved from a research-stage company to a leader in mRNA therapeutics, having developed vaccines and therapeutics for various diseases, including a highly effective COVID-19 vaccine.

CAMBRIDGE, MA / ACCESSWIRE / June 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following upcoming investor conferences:

• 2022 Jefferies Healthcare Conference on Wednesday, June 8^th at 3:00 p.m. ET
• 43^rd Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 14^th at 12:20 p.m. ET

A live webcast of each presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both ground-breaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most-effective vaccines against the COVID-19 pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: ModernaTX, Inc.

View source version on accesswire.com:
https://www.accesswire.com/703434/Moderna-to-Present-at-Upcoming-Conferences-in-June-2022

FAQ

When will Moderna present at the 2022 Jefferies Healthcare Conference?

Moderna will present at the 2022 Jefferies Healthcare Conference on June 8 at 3:00 p.m. ET.

What is the date and time of Moderna's presentation at the Goldman Sachs Global Healthcare Conference?

Moderna will present at the 43rd Annual Goldman Sachs Global Healthcare Conference on June 14 at 12:20 p.m. ET.

Where can I watch the Moderna investor conference presentations?

You can watch the live webcasts of Moderna's presentations under the "Events and Presentations" section on their investor website.

How long will the replays of Moderna's conference presentations be available?

The replays of Moderna's conference presentations will be archived on their website for at least 30 days.

What has been Moderna's recent achievement in vaccine development?

Moderna has developed one of the earliest and most effective vaccines against COVID-19.